This study will measure plasma concentrations of dexmedetomidine, fentanyl, morphine and midazolam in pediatric patients supported with extracorporeal membrane oxygenation (ECMO) aiming to understand the pharmacokinetics of these drugs in this setting.
supported on ECMO
receiving one or a combination of the following drugs dexmedetomidine, fentanyl, midazolam or morphine as part of sedation management
September 9, 2022
Primary Contact Information
Viviane Nasr, MD
For more information on this trial, visit clinicaltrials.gov.
For more information and to contact the study team: